ARTICLE | Company News
Perrigo, Transition Therapeutics deal
March 10, 2014 7:00 AM UTC
Transition acquired development and commercialization rights to neurology compound ELND005 from Perrigo. Transition will acquire Perrigo's Irish subsidiary responsible for development of the compound...